NCT01200329 High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease Status COMPLETED Phase PHASE2
NCT01190449 Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT01186224 Plerixafor Harvesting And No Chemotherapy for Transplantation of Autologous STem Cells In Cancer (PHANTASTIC) Status COMPLETED Phase NA
NCT01185886 Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia Status UNKNOWN Phase N/A
NCT01185548 A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymphoma Status TERMINATED Phase PHASE1
NCT01180569 Lenalidomide Therapy In Previously Untreated, Advanced Stage Follicular Lymphoma Status WITHDRAWN Phase PHASE1/PHASE2
NCT01169584 Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients Status COMPLETED Phase PHASE1
NCT01169532 Ridaforolimus and Vorinostat in Treating Patients With Advanced Solid Tumors or Lymphoma Status COMPLETED Phase PHASE1
NCT01168752 Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma Status COMPLETED Phase PHASE1
NCT01164709 Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer Status COMPLETED Phase PHASE1
NCT01162551 Trial of Sirolimus and Methotrexate in Relapsed/Refractory Lymphoblastic Leukemia and Lymphoma Status COMPLETED Phase PHASE2
NCT01160315 Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure Status COMPLETED Phase PHASE2/PHASE3
NCT01150643 Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab Status COMPLETED Phase N/A
NCT01149668 A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer Status COMPLETED Phase PHASE1
NCT01147991 Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer Status COMPLETED Phase PHASE1
NCT01144754 Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT Status TERMINATED Phase N/A
NCT01139359 Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma Status WITHDRAWN Phase PHASE1